Lupin gets EIR from USFDA for Pithampur facility
In November last, Lupin had received warning letter from USFDA (US Food and Drug Administration) for its manufacturing facilities in Goa and Pithampur.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news